HEART RATE REDUCTION WITH BETA-BLOCKERS REDUCED LEFT ATRIAL FUNCTION IN HYPERTENSIVE PATIENTS WITH RECURRENT ATRIAL FIBRILLATION

Elizaveta Kokhan,Gayrat Kiyakbaev,Zhanna Kobalava
DOI: https://doi.org/10.1097/01.hjh.0001022140.74160.ea
IF: 4.9
2024-05-01
Journal of Hypertension
Abstract:Objective: Higher resting heart rate (HR) has been shown to be an independent cardiovascular risk factor. However, some retrospective studies suggest that beta-blockers (BBs)-associated reduction in HR worsens left atrial (LA) function and increases the risk of stroke in hypertensive patients. Purpose: to assess the impact of HR reduction with BBs on LA function in hypertensive patients with paroxysmal or persistent mild symptomatic atrial fibrillation. Design and method: In this open prospective trial, we randomly assigned 91 patients with hypertension, elevated HR (>70 bpm, sinus rhythm) and recurrent atrial fibrillation with rare paroxysms to receive BBs with a target HR (sinus rhythm) of less or greater than 70 bpm. All patients underwent an echocardiogram at baseline and at the end of the study. Conventional echo measures and extended LA measures, including the minimal and maximal LA volumes (LAVmin and LAVmax) and LA emptying fraction (LAEF), were performed. The primary endpoint was the median LAEF measurement at the end of the study. Results: 47 patients were randomized to group with a target HR of = 70 bmp. Among them, 44 and 41 patients completed the study. The mean follow-up was 4.4 months. At the end of the study, median HR was 62 bmp in = 70 group (p<0.001). Both groups received similar antihypertensive therapy and there were no intergroup differences in systolic (129 vs 130; p=0.32) and diastolic (78 vs 78; p=0.53) blood pressure. Patients in = 70 group (37 vs 42%; p=0.02). Both groups had similar indices of LAVmin (22 vs 19ml/m2; p=0.66) and LAVmax (38 vs 37ml/m2). E/E’ and left ventricle mass index did not differ between study groups at the end of the study, but E’ was significantly lower in the =<70 group. Conclusions: Beta-blockers treatment with strict HR reduction (= 70 bpm). Although higher HR is a risk factor for hypertensive patients, its excess reduction with BBs could be harmful in this group.
peripheral vascular disease
What problem does this paper attempt to address?